Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites

Cancer Research

Volumn 71, Issue 21, 2011, Pages 6676-6683

  Phipps, Kyle D ^a   Surette, Alexi P ^a   O'Connell, Paul A ^a   Waisman, David M ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN RECEPTOR; PROTEIN S 100; PROTEIN S100A10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; FIBROSARCOMA; GENOTYPE; IN VIVO STUDY; LEWIS CARCINOMA; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; ANNEXIN A2; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; FIBROSARCOMA; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PLASMINOGEN; S100 PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 80155192757     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1748     Document Type: Article

References (21)

1. Lissbrant IF, Stattin P, Wikstrom P, Damber JE, Egevad L, Bergh A. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 2000;17: 445-51.
2. Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009;123:97-102.
3. Sica A, Saccani A, Mantovani A. Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol 2002;2:1045-54.
4. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-27.
5. Lewis C, Hughes R. Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2. Breast Cancer Res 2007;9:209.
6. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8. (Pubitemid 38082155)
7. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-6. (Pubitemid 43121975)
8. Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007;117:1155-66. (Pubitemid 46718400)
9. Das R, Burke T, Plow EF. Histone H2B as a functionally important plasminogen receptor on macrophages. Blood 2007;110:3763-72. (Pubitemid 350159647)
10. Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, Lohmeyer J, et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009;113:5588-98.
11. Plow EF, Das R. Enolase-1 as a plasminogen receptor. Blood 2009;113:5371-2.
12. O'Connell PA, Surette AP, Liwski RS, Svenningsson P, Waisman DM. S100A10 regulates plasminogen-dependent macrophage invasion. Blood 2010;116:1136-46.
13. Kwon M, Caplan JF, Filipenko NR, Choi K-S, Fitzpatrick SL, Zhang L, et al. Identification of annexin II heterotetramer as a plasmin reductase. J Biol Chem 2002;277:10903-11. (Pubitemid 34952845)
14. Monea S, Lehti K, Keski-Oja J, Mignatti P. Plasmin activates promatrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol 2002;192: 160-70. (Pubitemid 34747784)
15. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76.
16. Kwon M, MacLeod TJ, Zhang Y, Waisman DM. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005;10:300-25. (Pubitemid 40543035)
17. Zhang L, Fogg DK, Waisman DM. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 2004;279: 2053-62. (Pubitemid 38084477)
18. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AHM, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer 2006; 95:272-81. (Pubitemid 44187587)
19. Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 2002;19:247-58. (Pubitemid 34553525)
20. Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM, et al. Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Res 1990;10:579-82. (Pubitemid 20237802)
21. Surette AP, Madureira PA, Phipps KD, Miller VA, Svenningsson P, Waisman DM. Regulation of fibrinolysis by S100A10 in vivo. Blood. 2011 Jul 18. [Epub ahead of print].